Exp Cell Res. 2026 Nov 20. pii: S0014-4827(26)00354-X. [Epub ahead of print]
115237
Diabetic encephalopathy (DE) is a common central nervous system complication of diabetes, characterized by cognitive decline and neuroinflammation. Mitochondrial dysfunction is closely implicated in DE pathogenesis, yet the underlying mechanisms remain poorly understood. Here, by intersecting published diabetes-associated microglial genes with mitophagy-related genes, we identified SLC15A3, which was highly expressed in microglia. SLC15A3 overexpression induced microglial activation, oxidative stress, and neuroinflammation, manifested by increased IBA-1 expression, enhanced migration, elevated ROS and MDA levels, and upregulated pro-inflammatory cytokines. Conversely, SLC15A3 knockdown effectively reversed high glucose (HG)-induced microglial oxidative stress and inflammatory activation. Mechanistically, Nucleotide-binding Oligomerization Domain-containing protein 2 (NOD2) was identified as a candidate interacting protein of SLC15A3. SLC15A3 upregulated NOD2 expression to activate the downstream JNK/DRP1 signaling axis, thereby aggravating mitochondrial lipid peroxidation, reducing mitochondrial membrane potential, and triggering aberrant PINK1/Parkin-dependent mitophagy dysregulation. Notably, JNK knockdown significantly rescued SLC15A3-induced mitochondrial dysfunction. Importantly, this SLC15A3-NOD2 regulatory axis was further validated in primary murine microglia. In a microglia-endothelial co-culture blood-brain barrier (BBB) model, SLC15A3 silencing alleviated HG-evoked BBB permeability damage and restored the expression of tight junction proteins. In vivo hippocampal knockdown of SLC15A3 or NOD2 mitigated BBB disruption, reduced neuronal apoptosis, and partially attenuated cognitive deficits in DE mice. Collectively, this study demonstrates that SLC15A3 facilitated mitochondrial lipid peroxidation and mitophagy dysregulation via a NOD2-dependent JNK/DRP1 pathway, thereby accelerating BBB injury and DE progression. SLC15A3 represents a potential therapeutic target for diabetic cognitive complications.
Keywords: Diabetic encephalopathy; JNK/DRP1 signaling pathway; Microglia; Mitochondrial lipid peroxidation; SLC15A3